2024 ICD-10-CM Diagnosis Code C22.2

Hepatoblastoma

  • C22.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C22.2 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C22.2 – other international versions of ICD-10 C22.2 may differ.

The following code(s) above C22.2 contain annotation back-references

 that may be applicable to C22.2:

  • C00-D49  Neoplasms
  • C15-C26  Malignant neoplasms of digestive organs
  • C22  Malignant neoplasm of liver and intrahepatic bile ducts

Approximate Synonyms

  • Cancer of the liver, hepatoblastoma
  • Hepatoblastoma (clinical)

Clinical Information

  • (hep-a-toe-blas-toe-ma) a type of liver tumor that occurs in infants and children.
  • A malignant liver neoplasm composed of immature hepatocytic elements.
  • A malignant liver neoplasm that occurs almost exclusively in infants, although isolated cases in older children and adults have been reported. Grossly, hepatoblastoma is solid, well circumscribed, and more often solitary than multiple. Microscopically, most of the tumors are composed exclusively of immature hepatocytic elements. About a fourth of hepatoblastomas contain a stromal component that may be undifferentiated or develop into bone or cartilage. The treatment of choice for hepatoblastoma is surgical excision with adjuvant therapy. Liver transplantation is being increasingly used as well.
  • A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (stedman, 25th ed)
  • A type of liver tumor that occurs in infants and children.
  • Malignant liver neoplasm occurring in children and composed of tissue resembling fetal or mature liver cells or bile ducts.

ICD-10-CM C22.2 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 435 Malignancy of hepatobiliary system or pancreas with mcc
  • 436 Malignancy of hepatobiliary system or pancreas with cc
  • 437 Malignancy of hepatobiliary system or pancreas without cc/mcc

Convert C22.2 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to C22.2:

  • Hepatoblastoma C22.2
error: Content is protected !!